title: TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
abstract: The osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) cytokine system, not only controls bone homeostasis, but has been implicated in regulating vascular calcification. TNF-related apoptosis-inducing ligand (TRAIL) is a second ligand for OPG, and although its effect in vascular calcification in vitro is controversial, its role in vivo is not yet established. This study aimed to investigate the role of TRAIL in vascular calcification in vitro using vascular smooth muscle cells (VSMCs) isolated from TRAIL(-/-) and wild-type mice, as well as in vivo, in advanced atherosclerotic lesions of TRAIL(-/-)ApoE(-/-) mice. The involvement of OPG and RANKL in this process was also examined. TRAIL dose-dependently inhibited calcium-induced calcification of human VSMCs, while TRAIL(-/-) VSMCs demonstrated accelerated calcification induced by multiple concentrations of calcium compared to wild-type cells. Consistent with this, RANKL mRNA was significantly elevated with 24 h calcium treatment, while OPG and TRAIL expression in human VSMCs was inhibited. Brachiocephalic arteries from TRAIL(-/-)ApoE(-/-) and ApoE(-/-) mice fed a high fat diet for 12 w demonstrated increased chondrocyte-like cells in atherosclerotic plaque, as well as increased aortic collagen II mRNA expression in TRAIL(-/-)ApoE(-/-) mice, with significant increases in calcification observed at 20 w. TRAIL(-/-)ApoE(-/-) aortas also had significantly elevated RANKL, BMP-2, IL-1β, and PPAR-γ expression at 12 w. Our data provides the first evidence that TRAIL deficiency results in accelerated cartilaginous metaplasia and calcification in atherosclerosis, and that TRAIL plays an important role in the regulation of RANKL and inflammatory markers mediating bone turn over in the vasculature.
authors.affiliation: Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia.
authors.forename: Belinda A
authors.initials: BA
authors.lastname: Di Bartolo
authors.forename: Siân P
authors.initials: SP
authors.lastname: Cartland
authors.forename: Hanis H
authors.initials: HH
authors.lastname: Harith
authors.forename: Yuri V
authors.initials: YV
authors.lastname: Bobryshev
authors.forename: Michael
authors.initials: M
authors.lastname: Schoppet
authors.forename: Mary M
authors.initials: MM
authors.lastname: Kavurma
mesh_terms: D000818:Animals; D001011:Aorta / Q000378:metabolism* / Q000473:pathology; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics; D050197:Atherosclerosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D016122:Brachiocephalic Trunk / Q000378:metabolism* / Q000473:pathology; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D024043:Collagen Type II / Q000235:genetics / Q000378:metabolism; D059305:Diet, High-Fat; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D053244:Osteoprotegerin / Q000235:genetics / Q000378:metabolism; D058226:Plaque, Atherosclerotic / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D053245:RANK Ligand / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000172:deficiency / Q000235:genetics* / Q000494:pharmacology; D061205:Vascular Calcification / Q000235:genetics* / Q000378:metabolism / Q000473:pathology
chemical_list: D001057:Apolipoproteins E; D024043:Collagen Type II; D053244:Osteoprotegerin; D053245:RANK Ligand; D012333:RNA, Messenger; D053221:TNF-Related Apoptosis-Inducing Ligand; C506030:TNFRSF11B protein, human; D002118:Calcium
references.citation: Arthritis Rheum. 2004 Feb;50(2):534-42
references.pmid: 14872496
references.citation: J Biol Chem. 2008 Mar 21;283(12):7754-62
references.pmid: 18178561
references.citation: Circ Res. 2010 Apr 2;106(6):1061-71
references.pmid: 20150555
references.citation: J Cell Physiol. 2008 Jul;216(1):144-52
references.pmid: 18247361
references.citation: Osteoarthritis Cartilage. 2000 Sep;8(5):309-34
references.pmid: 10966838
references.citation: Biochem Pharmacol. 2008 Apr 1;75(7):1441-50
references.pmid: 18061141
references.citation: Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1420-5
references.pmid: 15845913
references.citation: Circ Res. 2004 Nov 26;95(11):1046-57
references.pmid: 15564564
references.citation: Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1610-6
references.pmid: 11597934
references.citation: Immunity. 1995 Dec;3(6):673-82
references.pmid: 8777713
references.citation: Z Kardiol. 2001;90 Suppl 3:116-24
references.pmid: 11374023
references.citation: Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2030-4
references.pmid: 18703777
references.citation: Thromb Haemost. 2005 Dec;94(6):1335-7
references.pmid: 16411417
references.citation: Circ Res. 2009 May 8;104(9):1041-8
references.pmid: 19325147
references.citation: Arterioscler Thromb Vasc Biol. 2000 May;20(5):1257-61
references.pmid: 10807741
references.citation: J Clin Endocrinol Metab. 2003 Mar;88(3):1024-8
references.pmid: 12629080
references.citation: Diabetologia. 2011 Dec;54(12):3157-67
references.pmid: 21965021
references.citation: Mol Cell Endocrinol. 2012 Oct 15;362(1-2):149-56
references.pmid: 22698523
references.citation: Int J Oncol. 2006 Jan;28(1):261-9
references.pmid: 16328004
references.citation: Nature. 1999 Jan 28;397(6717):315-23
references.pmid: 9950424
references.citation: Genes Dev. 1998 May 1;12(9):1260-8
references.pmid: 9573043
references.citation: J Pathol. 2005 Apr;205(5):641-50
references.pmid: 15776485
references.citation: JAMA. 2004 Jul 28;292(4):490-5
references.pmid: 15280347
references.citation: Lab Invest. 2011 Oct;91(10):1434-42
references.pmid: 21555997
references.citation: J Mol Cell Cardiol. 2004 Jan;36(1):57-66
references.pmid: 14734048
references.citation: Cell Mol Life Sci. 2013 Oct;70(19):3617-29
references.pmid: 23329170
references.citation: Clin Orthop Relat Res. 2004 Oct;(427 Suppl):S27-36
references.pmid: 15480070
references.citation: Atherosclerosis. 2011 Apr;215(2):452-8
references.pmid: 21122855
references.citation: Nature. 1997 Mar 6;386(6620):78-81
references.pmid: 9052783
references.citation: Cardiovasc Res. 2011 Aug 1;91(3):537-45
references.pmid: 21447702
references.citation: Circ Res. 2006 Nov 10;99(10):1044-59
references.pmid: 17095733
references.citation: J Exp Med. 2006 Jan 23;203(1):239-50
references.pmid: 16418392
references.citation: Am J Pathol. 2010 Jul;177(1):473-80
references.pmid: 20489139
references.citation: Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):549-53
references.pmid: 11950689
references.citation: J Nucl Cardiol. 2003 Mar-Apr;10(2):177-83
references.pmid: 12673183
references.citation: J Biol Chem. 2010 Sep 24;285(39):29925-31
references.pmid: 20663885
references.citation: J Exp Med. 2012 Oct 22;209(11):1919-35
references.pmid: 23071256
references.citation: Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1694-702
references.pmid: 18669890
references.citation: J Cell Biochem. 2012 Aug;113(8):2597-606
references.pmid: 22415975
references.citation: Diabetes. 2011 Aug;60(8):2187-96
references.pmid: 21659498
references.citation: J Biol Chem. 2003 Sep 5;278(36):34387-94
references.pmid: 12815054
references.citation: Circ Res. 2005 Jul 22;97(2):105-14
references.pmid: 16037577
references.citation: Circulation. 2002 Sep 3;106(10):1192-4
references.pmid: 12208791
references.citation: Circulation. 2008 Jan 22;117(3):411-20
references.pmid: 18172035
references.citation: FASEB J. 2003 Sep;17(12):1751-3
references.pmid: 12958198
references.citation: Ther Apher Dial. 2011 Apr;15(2):140-6
references.pmid: 21426505
references.citation: Anal Biochem. 2004 Jun 1;329(1):77-84
references.pmid: 15136169
references.citation: Biochem Biophys Res Commun. 2007 Jun 22;358(1):18-23
references.pmid: 17490621
references.citation: Circulation. 2006 Oct 3;114(14):1522-30
references.pmid: 17000905
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11201-6
references.pmid: 14500910
references.citation: Circ Res. 2009 Mar 27;104(6):733-41
references.pmid: 19197075
references.citation: Am J Pathol. 2009 Aug;175(2):473-8
references.pmid: 19590040
references.citation: Calcif Tissue Int. 2012 Dec;91(6):379-86
references.pmid: 23052229
references.citation: Biochem Biophys Res Commun. 2002 Jun 14;294(3):597-601
references.pmid: 12056809
references.citation: Circulation. 2003 Mar 25;107(11):e76; author reply e76
references.pmid: 12654623
references.citation: J Clin Endocrinol Metab. 2001 Feb;86(2):631-7
references.pmid: 11158021
references.citation: Circ Res. 2010 Aug 20;107(4):466-75
references.pmid: 20595654
references.citation: Nat Med. 2007 Dec;13(12):1496-503
references.pmid: 18059282
references.citation: J Biol Chem. 2001 Jun 8;276(23):20659-72
references.pmid: 11274143
references.citation: Calcif Tissue Int. 2004 Jan;74(1):103-6
references.pmid: 14523602
references.citation: Cell Death Differ. 2013 Jul;20(7):858-68
references.pmid: 23579241
references.citation: Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):331-6
references.pmid: 14656730
references.citation: PLoS One. 2011;6(12):e29037
references.pmid: 22194983
references.citation: Blood. 2004 Oct 1;104(7):2044-50
references.pmid: 15213096
references.citation: Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1387-96
references.pmid: 21454810
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):4104-12
references.pmid: 15292354